[Gastroduodenal mucosal lesions and coronary atherosclerosis severity in patients with coronary artery disease]

Marko Banić1, Damir Fabijanić, Dusko Kardum

  • 1Zavod za gastroenterologiju i hepatologiju, Klinika za unutarnje bolesti KB Dubrava Zagreb.

Lijecnicki Vjesnik
|December 10, 2008
PubMed

Insights

In coronary artery disease (CAD) patients, ischemia does not significantly contribute to gastroduodenal (GD) mucosa impairment. This study found no correlation between the severity of coronary atherosclerosis and GD mucosal lesions, suggesting ischemia plays a minor role.

Area of Science:

  • Gastroenterology
  • Cardiology
  • Pathophysiology

Context:

  • Gastroduodenal (GD) mucosa is highly metabolically active, making it susceptible to ischemia.
  • Coronary artery disease (CAD) involves atherosclerosis, potentially impacting blood supply to other organs.
  • Understanding the link between CAD severity and GD mucosal lesions is crucial for patient management.

Purpose:

  • To investigate the potential contribution of ischemia to gastroduodenal (GD) mucosal impairment in patients with coronary artery disease (CAD).
  • To compare the severity of coronary atherosclerosis with the prevalence and severity of GD mucosal lesions.

Summary:

  • This prospective study analyzed 150 CAD patients, assessing coronary atherosclerosis severity using multiple scores and GD mucosal lesions via the Lanza score.
  • No significant difference in CAD severity was observed between patients with and without GD mucosal lesions.
  • No correlation was found between the severity of CAD and the severity of GD mucosal lesions, including Helicobacter pylori infection status.

Impact:

  • The findings suggest that ischemia has a minimal or no role in the pathogenesis of GD mucosal impairment in CAD patients.
  • This research may influence clinical approaches to managing GD issues in patients with cardiovascular conditions.
  • Highlights the need for further research into other factors contributing to GD mucosal lesions in CAD patients.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...